Business
Adlai Nortye, 230 milyon dolarlık anlaşmayla kanser ilacını ASK Pharm’a lisansladı
SOURCE:Investing Türkiye|BY:Investing.com
Failed to fetch content: Request failed with error code 403
Failed to fetch content: Request failed with error code 403